MENU
+Compare
GMAB
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$20.80
Change
-$0.42 (-1.98%)
Capitalization
13.38B

GMAB Genmab A/S ADS Forecast, Technical & Fundamental Analysis

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GMAB with price predictions
Jan 14, 2025

GMAB in -2.30% downward trend, sliding for three consecutive days on January 14, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GMAB declined for three days, in of 286 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for GMAB moved out of overbought territory on January 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

GMAB broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 27, 2024. You may want to consider a long position or call options on GMAB as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GMAB just turned positive on December 26, 2024. Looking at past instances where GMAB's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

GMAB moved above its 50-day moving average on January 06, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GMAB crossed bullishly above the 50-day moving average on January 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GMAB advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GMAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.998) is normal, around the industry mean (14.746). P/E Ratio (20.825) is within average values for comparable stocks, (87.786). Projected Growth (PEG Ratio) (0.754) is also within normal values, averaging (1.852). GMAB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (4.943) is also within normal values, averaging (263.573).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GMAB is expected to report earnings to rise 23.54% to 35 cents per share on February 12

Genmab A/S ADS GMAB Stock Earnings Reports
Q4'24
Est.
$0.35
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Est.
$0.29
Q4'23
Missed
by $0.17
The last earnings report on November 06 showed earnings per share of 28 cents, missing the estimate of 30 cents. With 1.12M shares outstanding, the current market capitalization sits at 13.38B.
A.I. Advisor
published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

GMAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GMAB has been loosely correlated with CVAC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GMAB jumps, then CVAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMAB
1D Price
Change %
GMAB100%
-1.98%
CVAC - GMAB
39%
Loosely correlated
-1.91%
TECH - GMAB
35%
Loosely correlated
-0.35%
RIGL - GMAB
32%
Poorly correlated
+16.02%
INO - GMAB
32%
Poorly correlated
+8.90%
ARCT - GMAB
32%
Poorly correlated
-1.29%
More